LLMpediaThe first transparent, open encyclopedia generated by LLMs

Amy Schulman

Generated by DeepSeek V3.2
⚠Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Polaris Partners Hop 4
Expansion Funnel Raw 36 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted36
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Amy Schulman
NameAmy Schulman
EducationYale University (BA), Harvard Law School (JD)
OccupationLawyer, business executive, investor
Known forLeadership at Pfizer, CEO of Lyndra Therapeutics, founding partner of Daphni

Amy Schulman is an American lawyer, business executive, and investor renowned for her leadership in the pharmaceutical and legal industries. She served as the Executive Vice President and General Counsel of Pfizer, where she also led the company's consumer healthcare business. Schulman is a managing partner of the venture capital firm Polaris Partners and the CEO of the biotech company Lyndra Therapeutics.

Early life and education

Schulman was raised in New York City and attended the Dalton School. She earned her Bachelor of Arts in English from Yale University, where she was a member of the Yale Debate Association. She subsequently received her Juris Doctor from Harvard Law School, graduating cum laude.

Schulman began her legal career as an associate at Cravath, Swaine & Moore in New York City. She later became a partner at the international law firm DLA Piper, where she chaired the Mass Torts and Product Liability practice. At DLA Piper, she represented major corporations like General Electric and Pfizer in high-stakes litigation. Her work defending Pfizer in cases involving the drug Zoloft led to her recruitment by the pharmaceutical giant.

Business career

In 2008, Schulman joined Pfizer as Executive Vice President and General Counsel, overseeing global legal affairs, compliance, and government relations. She was later given additional responsibility as President of Pfizer Nutrition and then as President of Pfizer Consumer Healthcare, where she managed brands such as Centrum and Advil. After leaving Pfizer, she became a managing partner at the venture capital firm Polaris Partners, focusing on healthcare investments. In 2017, she assumed the role of CEO at Lyndra Therapeutics, a clinical-stage company developing long-acting oral therapies. She is also a founding partner of the European venture firm Daphni.

Board memberships and philanthropy

Schulman serves on the boards of several prominent public companies, including The New York Times Company, Akamai Technologies, and Vertex Pharmaceuticals. She is a member of the board of trustees for Yale University and the Museum of Modern Art in New York City. Her philanthropic efforts are channeled through organizations like the Robin Hood Foundation and the Innocence Project.

Personal life

Schulman is married to Matthew Martoma, a former portfolio manager for the hedge fund SAC Capital Advisors. The family resides in New York City and maintains a residence in Martha's Vineyard. She is an avid art collector and a supporter of various cultural institutions, including the Whitney Museum of American Art.

Category:American lawyers Category:American business executives Category:American women chief executives Category:Harvard Law School alumni Category:Yale University alumni